Back

E3 Trial: The 52-Week Results

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Latest Science in CV Prevention Tobacco ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Kristian Filion

Montreal (Canada)

6 More presentations in this session

Presentation thumbnail
Nationwide trends in stroke and atrial fibrillation in patients with incident type 2 diabetes
Doctor C. Gyldenkerne (Aarhus, DK)
Slides Video
Presentation thumbnail
CRISP-CT: Incorporating FAI-Score In Clinical Decision Making
Professor C. Antoniades (Oxford, GB)
Slides Video
Presentation thumbnail
Opiates and its effects on cardiovascular outcomes
Doctor S. Liew (Melbourne, AU)
Slides Video
Presentation thumbnail
Long term effects of the Randomized Evaluation of Secondary Prevention by Outpatient Nurse Specialists-2 trial (RESPONSE-2)
Doctor H. Jorstad (Amsterdam, NL)
Slides Video
Presentation thumbnail
Metabolic Surgery and Risk of MACE in NASH
Doctor A. Aminian (Cleveland, US)
Slides Video

Access the full session

Session thumbnail
Latest Science in CV Prevention

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Tobacco
thumbnail
Congress Presentation
Tobacco-free hospitals: a game-changer in cardiovascular health
thumbnail
Congress Presentation
Trajectories in smoking habits and outcomes in patients with stable coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources